Cleared Traditional

OEC 9800 E/CV+ DIGITAL MOBILE IMAGING SYSTEM (K024012) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2003
Decision
106d
Days
Class 2
Risk

K024012 is an FDA 510(k) clearance for the OEC 9800 E/CV+ DIGITAL MOBILE IMAGING SYSTEM. Classified as System, X-ray, Fluoroscopic, Image-intensified (product code JAA), Class II - Special Controls.

Submitted by Ge Oec Medical Systems (Salt Lake City, US). The FDA issued a Cleared decision on March 20, 2003 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ge Oec Medical Systems devices

Submission Details

510(k) Number K024012 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 04, 2002
Decision Date March 20, 2003
Days to Decision 106 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 107d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAA System, X-ray, Fluoroscopic, Image-intensified
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAA System, X-ray, Fluoroscopic, Image-intensified

All 57
Devices cleared under the same product code (JAA) and FDA review panel - the closest regulatory comparables to K024012.
UROSKOP OMNIA
K101491 · Siemens Medical Solutions USA, Inc. · Jun 2010
SMITH & NEPHEW CDS SYSTEM
K081491 · Smith & Nephew, Inc. · Jun 2008
SMITH & NEPHEW CDS SYSTEM
K051136 · Smith & Nephew, Inc. · Jul 2005
MODULAR ANGIOGRAPHY SYSTEM AXIOM ARTIS
K021021 · Siemens Medical Solutions USA, Inc. · Jun 2002
CAREGRAPH
K982319 · Siemens Medical Solutions USA, Inc. · Sep 1998
FLUOROSPOT COMPACT
K982028 · Siemens Medical Solutions USA, Inc. · Jul 1998